Aventis Drug Candidate Assessment Finds Half Fail Due To Safety Concerns
Almost half of Aventis' new drug candidates fail during development because of safety or toxicity concerns, the drug manufacturer's internal data from 2003 show
Almost half of Aventis' new drug candidates fail during development because of safety or toxicity concerns, the drug manufacturer's internal data from 2003 show